Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
celgene
2
×
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
2019
activism
acute hepatic porphyria
aimmune therapeutics
alnylam pharmaceuticals
alopecia areata
amarin
arena pharmaceuticals
avapritinib
bernie sanders
blueprint medicines
boehringer ingelheim
What
bio
deals
2
×
roundup
advanced
alnylam’s
approval
arena’s
bff
bounty
cig
comeback
companies
conference
corner
delivered
devoted
disease
drug
easl
expressing
form
gene
ipo
kicked
life
little
liver
major
moderna’s
number
race
science
survey
thanks
thanksgiving
therapy
treat
updates
week
world's
Language
Current search:
deals
×
celgene
×
@xconomy.com
5 years ago
Bio Roundup: EASL Does It, Alnylam’s BFF, Gene Therapy Deals & More
@xconomy.com
5 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More
